The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs
Open accessAbstract
Treatment effects, especially when comparing two or more therapeutic alternatives as in comparative effectiveness research, are likely to be heterogeneous across age, gender, co‐morbidities and co‐medications. Propensity scores (PS s), an alternative to multivariable outcome models to control for measured confounding, have specific advantages in the presence of heterogeneous treatment effects. Implementing PS s using matching or weighting allows us to estimate different overall treatment effects in differently defined populations. Heterogeneous treatment effects can also be due to unmeasured confounding concentrated in those treated contrary to prediction. Sensitivity analyses based on PS s can help to assess such unmeasured confounding. PS s should be considered a primary or secondary analytic strategy in nonexperimental medical research, including pharmacoepidemiology and nonexperimental comparative effectiveness research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689 · cited 1×
“, Mantel-Haenszel; MH [42]) is a well-established method to control for confounding by any continuous covariate, including the PS.”
Causality: Models, Reasoning, and Inference
Pearl, J. (2009) · doi:10.1017/cbo9780511803161 · Cited by 11,653
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
CAUSALITY: MODELS, REASONING AND INFERENCE
Hitchcock, C. (2001) · The Philosophical Review · doi:10.1215/00318108-110-4-639 · Cited by 4,741
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Modern Epidemiology 3rd edition
Rothman, K. J., Lash, T. L., & Greenland, S. (1986) · Cited by 3,097
Causality: models, reasoning, and inference
(2000) · Choice Reviews Online · doi:10.5860/choice.38-1494a · Cited by 2,873
Cited by
Larsen, T. B., Skjøth, F., Nielsen, P. B., Kjældgaard, J. N., & Lip, G. Y. H. (2016) · BMJ · doi:10.1136/bmj.i3189 · Cited by 441
Nielsen, P. B., Skjøth, F., Søgaard, M., Kjældgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017) · BMJ · doi:10.1136/bmj.j510 · Cited by 346
Chen, R. C., Basak, R., Meyer, A.-M., Kuo, T.-M., Carpenter, W. R., Agans, R. P., Broughman, J. R., Reeve, B. B., Nielsen, M. E., Usinger, D. S., et al. (2017) · JAMA · doi:10.1001/jama.2017.1652 · Cited by 325
Self-citationNg, B., Chu, A., & Khan, M. M. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002468 · Cited by 301
Vinogradova, Y., Coupland, C., Hill, T., & Hippisley-Cox, J. (2018) · BMJ · doi:10.1136/bmj.k2505 · Cited by 275
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4369 · Cited by 103
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease
Simmering, J. E., Welsh, M. J., Liu, L., Narayanan, N. S., & Pottegård, A. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.5157 · Cited by 84
HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia
Vetrova, M. V., Cheng, D. M., Bendiks, S., Gnatienko, N., Lloyd-Travaglini, C., Jiang, W., Luoma, J., Blokhina, E., Krupitsky, E., Lioznov, D., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03172-5 · Cited by 52
Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.08.034 · Cited by 34
Han, L., Goulet, J. L., Skanderson, M., Bathulapalli, H., Luther, S. L., Kerns, R. D., & Brandt, C. A. (2019) · Pain Medicine · doi:10.1093/pm/pny027 · Cited by 18
Metadata
- Authors
- Stürmer, T., Wyss, R., Glynn, R. J., & Brookhart, M. A.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2014-02-13
- Volume
- 275
- Issue
- 6
- Pages
- 570-580
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1981535076
- Cited by
- 302
- References
- 58
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.